Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Shattuck Labs, Inc. (STTK) Guidance & Earnings Results

On 2026-05-07 Shattuck Labs, Inc. reaffirmed guidance: "Cash runway into 2029; no revenue…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

STTKShattuck Labs, Inc.Follow STTK — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
551.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
10 Nov, in 17 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
7 May 26ReaffirmedCash runway into 2029; no revenue guidance. · full year
6 Nov 25—Cash runway into 2029 assuming full warrant exercise

Shattuck Labs, Inc. — questions

What guidance did Shattuck Labs, Inc. give?
On 2026-05-07: "Cash runway into 2029; no revenue guidance."
When does Shattuck Labs, Inc. report earnings?
Shattuck Labs, Inc.'s next earnings report is expected on 2026-11-10.

Every figure on this page comes from Shattuck Labs, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.